Health

UniQure’s Huntington’s Gene Therapy Readout Expected Soon

Updated 2026-09-10 10:40 UTC 1 source Neutral

UniQure is set to report four-year results from its clinical trial of a gene therapy for Huntington's disease before the end of September.

Coverage timeline — 2 articles
STAT News
Before the end of September, UniQure is expected to report four-year results from the closely tracked clinical trial of its gene therapy for Huntington’s disease.
2026-09-10 10:30 UTC
STAT News
A Roivant lung disease drug has succeeded in a mid-stage study. But the drug’s origins are another fascinating aspect to the story.
2026-09-10 10:30 UTC
Share: Twitter / X LinkedIn